Cargando…
Short-Term Effectiveness and Safety of Biologics and Small Molecule Drugs for Moderate to Severe Atopic Dermatitis: A Systematic Review and Network Meta-Analysis
Background: Some Network Meta-analysis (NMA) has been published regarding atopic dermatitis (AD). These studies have considered drugs under investigation both in monotheraphy or in combination with topical corticosteroids, as well as systemic immunosuppressant therapies. The objective of this study...
Autores principales: | Pereyra-Rodriguez, José-Juan, Alcantara-Luna, Sara, Domínguez-Cruz, Javier, Galán-Gutiérrez, Manuel, Ruiz-Villaverde, Ricardo, Vilar-Palomo, Samuel, Armario-Hita, Jose-Carlos |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8470048/ https://www.ncbi.nlm.nih.gov/pubmed/34575076 http://dx.doi.org/10.3390/life11090927 |
Ejemplares similares
-
Long-Term Effectiveness and Safety of Biologic and Small Molecule Drugs for Moderate to Severe Atopic Dermatitis: A Systematic Review
por: Ayen-Rodríguez, Angela, et al.
Publicado: (2022) -
Validation of a Questionnaire to Assess the Perception of Women with Atopic Dermatitis in Family Planning
por: Alcantara-Luna, Sara, et al.
Publicado: (2022) -
Atopic Dermatitis: Background, Objectives and Future Perspectives (Superresponders)
por: Ruiz-Villaverde, Ricardo, et al.
Publicado: (2022) -
104-week safety and effectiveness of dupilumab in the treatment of severe atopic dermatitis. The experience of 5 reference dermatology units in Spain()()
por: Pereyra-Rodriguez, Jose Juan, et al.
Publicado: (2021) -
Clinical Approach to Patients with Moderate-to-Severe Atopic Dermatitis: A Spanish Delphi Consensus
por: PEREYRA-RODRIGUEZ, Jose J., et al.
Publicado: (2023)